pd0325901 Search Results


94
Miltenyi Biotec pd0325901
Pd0325901, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd0325901/StemMACS+PD0325901/pm37592709-36-19-20
Average 94 stars, based on 1 article reviews
pd0325901 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

92
MedChemExpress small chemical inhibitors
TGF-β and Hippo signaling coordinately regulate CYR61 gene transcription. A and B , HCCLM3 or HLE cells were treated with 2.5 ng/ml of TGF-β1 in the presence or absence of small chemical <t>inhibitors</t> of different signaling pathways for 24 h, followed by gene expression analyses by quantitative PCR ( A ) or Western blotting ( B ). TGF-β type I receptor inhibitor, SB431542 (5 μM); YAP inhibitor, verteporfin (5 μM); MEK inhibitor, PD0325901 (5 μM); JNK inhibitor, SP600125 (5 μM); GSK-3 inhibitor, SB216763 (5 μM); NF-κB inhibitor, JSH-23 (5 μM); PI3K inhibitor, LY294002 (5 μM); ERK1/2 inhibitor, LY3214996 (5 μM). C , HLE or HCCLM3 cells treated with 2.5 ng/ml of TGF-β1 and/or 3 μM of XMU-MP-1 for 24 h were harvested for protein expression detection by Western blotting. D and E , HLE or HCCLM3 cells were treated with 2.5 ng/ml of TGF-β1 ( D ) or 3 μM of XMU-MP-1 ( E ) for 24 h, in the presence or absence of 5 μM of SB431542 and/or 5 μM of verteporfin. Then cells were analyzed by Western blotting. F and G , liver cancer cells transfected with siRNAs were treated with or without 2.5 ng/ml of TGF-β1 ( F ) or 3 μM of XMU-MP-1 ( G ) for 24 h before being harvested for Western blotting analyses. TGF-β, transforming growth factor-β.
Small Chemical Inhibitors, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd0325901/PD0325901-O-C2-dioxolane/pmc11021963-227-0-26
Average 92 stars, based on 1 article reviews
small chemical inhibitors - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

96
Tocris pd0325901
TGF-β and Hippo signaling coordinately regulate CYR61 gene transcription. A and B , HCCLM3 or HLE cells were treated with 2.5 ng/ml of TGF-β1 in the presence or absence of small chemical <t>inhibitors</t> of different signaling pathways for 24 h, followed by gene expression analyses by quantitative PCR ( A ) or Western blotting ( B ). TGF-β type I receptor inhibitor, SB431542 (5 μM); YAP inhibitor, verteporfin (5 μM); MEK inhibitor, PD0325901 (5 μM); JNK inhibitor, SP600125 (5 μM); GSK-3 inhibitor, SB216763 (5 μM); NF-κB inhibitor, JSH-23 (5 μM); PI3K inhibitor, LY294002 (5 μM); ERK1/2 inhibitor, LY3214996 (5 μM). C , HLE or HCCLM3 cells treated with 2.5 ng/ml of TGF-β1 and/or 3 μM of XMU-MP-1 for 24 h were harvested for protein expression detection by Western blotting. D and E , HLE or HCCLM3 cells were treated with 2.5 ng/ml of TGF-β1 ( D ) or 3 μM of XMU-MP-1 ( E ) for 24 h, in the presence or absence of 5 μM of SB431542 and/or 5 μM of verteporfin. Then cells were analyzed by Western blotting. F and G , liver cancer cells transfected with siRNAs were treated with or without 2.5 ng/ml of TGF-β1 ( F ) or 3 μM of XMU-MP-1 ( G ) for 24 h before being harvested for Western blotting analyses. TGF-β, transforming growth factor-β.
Pd0325901, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd0325901/PD+0325901/pm35439430-282-10-16
Average 96 stars, based on 1 article reviews
pd0325901 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc pd325901 mek inhibitor

Pd325901 Mek Inhibitor, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd0325901/PD+0325901/pmc08554532-11-0-4
Average 93 stars, based on 1 article reviews
pd325901 mek inhibitor - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

96
MedChemExpress mek inhibitor mek1 2 inhibitor pd 0325901

Mek Inhibitor Mek1 2 Inhibitor Pd 0325901, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd0325901/Mirdametinib/bio_rxiv__64898__2026__06__19__733436-285-28-40
Average 96 stars, based on 1 article reviews
mek inhibitor mek1 2 inhibitor pd 0325901 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

93
Biogems International pd0325901
a Schematic overview of the loss-of-function screen experimental setup. Haploid parthenogenetic hESCs infected with a genome-wide CRISPR/Cas9 sgRNA library, were stained with an antibody against the paternally expressed gene PEG10 (normally silenced in these cells). This was followed by FACS sorting to isolate the PEG10-positive (PEG10 + ) cell population. Finally, targeted DNA sequencing of sgRNAs identifies enriched genes mutated in PEG10 + cells compared with unsorted control. b Histogram showing the flow cytometry analysis of PEG10 staining in androgenetic (blue) vs. parthenogenetic (red) cells. c Representative scatter plots of the flow cytometry analysis of PEG10 staining in secondary only control (left), haploid parthenogenetic CRISPR/Cas9 library cells (center) and bi-parental cells (right). y Axis represents the fluorescence intensity of PEG10 staining, while the x axis represents the autofluorescence signal. d Volcano plot showing the median log 2 fold change (FC) of normalized sgRNA read counts (calculated by edgeR) per gene, between PEG10 + and unsorted control ( x axis, values are normalized to zero. n = 4 replicate screens). y Axis represents −log 10 of the P value (two-sample, two-sided Kolmogorov-Smirnov test). Marked in blue are enriched genes having log FC > 0.5 (equivalent to normalized value >1.4) and P value < 0.05. Representative genes included in the “EpiFactors” database (orange), zinc finger proteins (purple) and tumor suppressors (blue) are indicated. e Pie chart subgrouping the 115 candidate genes by function (after removing genes enriched in the PEG10-negative control). Chromatin-related genes are further divided to subcategories: Genes included in the EpiFactors database, genes encoding zinc finger proteins (ZNFP) and those encoding transcription factors (TF). f Mean expression FC of PEGs between hpESCs treated with the MEK/ERK inhibitor <t>PD0325901</t> and DMSO. n = 4 replicates from each treatment in two different cell lines. Data are presented as mean ± SEM. Shown are PEGs with FC > 1. P values are listed in gray (one-tailed, paired t -test).
Pd0325901, supplied by Biogems International, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd0325901/PD+0325901/pmc08602306-242-13-14
Average 93 stars, based on 1 article reviews
pd0325901 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

94
MedChemExpress mg132 proteasome inhibitor
a Schematic overview of the loss-of-function screen experimental setup. Haploid parthenogenetic hESCs infected with a genome-wide CRISPR/Cas9 sgRNA library, were stained with an antibody against the paternally expressed gene PEG10 (normally silenced in these cells). This was followed by FACS sorting to isolate the PEG10-positive (PEG10 + ) cell population. Finally, targeted DNA sequencing of sgRNAs identifies enriched genes mutated in PEG10 + cells compared with unsorted control. b Histogram showing the flow cytometry analysis of PEG10 staining in androgenetic (blue) vs. parthenogenetic (red) cells. c Representative scatter plots of the flow cytometry analysis of PEG10 staining in secondary only control (left), haploid parthenogenetic CRISPR/Cas9 library cells (center) and bi-parental cells (right). y Axis represents the fluorescence intensity of PEG10 staining, while the x axis represents the autofluorescence signal. d Volcano plot showing the median log 2 fold change (FC) of normalized sgRNA read counts (calculated by edgeR) per gene, between PEG10 + and unsorted control ( x axis, values are normalized to zero. n = 4 replicate screens). y Axis represents −log 10 of the P value (two-sample, two-sided Kolmogorov-Smirnov test). Marked in blue are enriched genes having log FC > 0.5 (equivalent to normalized value >1.4) and P value < 0.05. Representative genes included in the “EpiFactors” database (orange), zinc finger proteins (purple) and tumor suppressors (blue) are indicated. e Pie chart subgrouping the 115 candidate genes by function (after removing genes enriched in the PEG10-negative control). Chromatin-related genes are further divided to subcategories: Genes included in the EpiFactors database, genes encoding zinc finger proteins (ZNFP) and those encoding transcription factors (TF). f Mean expression FC of PEGs between hpESCs treated with the MEK/ERK inhibitor <t>PD0325901</t> and DMSO. n = 4 replicates from each treatment in two different cell lines. Data are presented as mean ± SEM. Shown are PEGs with FC > 1. P values are listed in gray (one-tailed, paired t -test).
Mg132 Proteasome Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd0325901/Mirdametinib/pmc11350581__au4c00278_si_001-14-0-14
Average 94 stars, based on 1 article reviews
mg132 proteasome inhibitor - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
Miltenyi Biotec pd0325901 miltenyi 130 106 541 gelatin panbiotech p06 20410 dmem f12 media thermoscientific 21331020 kosr lifetechnologies
a Schematic overview of the loss-of-function screen experimental setup. Haploid parthenogenetic hESCs infected with a genome-wide CRISPR/Cas9 sgRNA library, were stained with an antibody against the paternally expressed gene PEG10 (normally silenced in these cells). This was followed by FACS sorting to isolate the PEG10-positive (PEG10 + ) cell population. Finally, targeted DNA sequencing of sgRNAs identifies enriched genes mutated in PEG10 + cells compared with unsorted control. b Histogram showing the flow cytometry analysis of PEG10 staining in androgenetic (blue) vs. parthenogenetic (red) cells. c Representative scatter plots of the flow cytometry analysis of PEG10 staining in secondary only control (left), haploid parthenogenetic CRISPR/Cas9 library cells (center) and bi-parental cells (right). y Axis represents the fluorescence intensity of PEG10 staining, while the x axis represents the autofluorescence signal. d Volcano plot showing the median log 2 fold change (FC) of normalized sgRNA read counts (calculated by edgeR) per gene, between PEG10 + and unsorted control ( x axis, values are normalized to zero. n = 4 replicate screens). y Axis represents −log 10 of the P value (two-sample, two-sided Kolmogorov-Smirnov test). Marked in blue are enriched genes having log FC > 0.5 (equivalent to normalized value >1.4) and P value < 0.05. Representative genes included in the “EpiFactors” database (orange), zinc finger proteins (purple) and tumor suppressors (blue) are indicated. e Pie chart subgrouping the 115 candidate genes by function (after removing genes enriched in the PEG10-negative control). Chromatin-related genes are further divided to subcategories: Genes included in the EpiFactors database, genes encoding zinc finger proteins (ZNFP) and those encoding transcription factors (TF). f Mean expression FC of PEGs between hpESCs treated with the MEK/ERK inhibitor <t>PD0325901</t> and DMSO. n = 4 replicates from each treatment in two different cell lines. Data are presented as mean ± SEM. Shown are PEGs with FC > 1. P values are listed in gray (one-tailed, paired t -test).
Pd0325901 Miltenyi 130 106 541 Gelatin Panbiotech P06 20410 Dmem F12 Media Thermoscientific 21331020 Kosr Lifetechnologies, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd0325901/StemMACS+PD0325901+in+Solution/pm39837330-855-111-112
Average 94 stars, based on 1 article reviews
pd0325901 miltenyi 130 106 541 gelatin panbiotech p06 20410 dmem f12 media thermoscientific 21331020 kosr lifetechnologies - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

95
ReproCELL mek1 2 inhibitor pd0325901
Key Resources Table
Mek1 2 Inhibitor Pd0325901, supplied by ReproCELL, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd0325901/Stemolecule+PD0325901/pmc11613955-22-0-4
Average 95 stars, based on 1 article reviews
mek1 2 inhibitor pd0325901 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

90
LC Laboratories pd0325901
Key Resources Table
Pd0325901, supplied by LC Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd0325901/pd0325901/10__1158_slash_0008___5472__can___16___2593-38-13-11
Average 90 stars, based on 1 article reviews
pd0325901 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
ESI Bio pd-0325901
Key Resources Table
Pd 0325901, supplied by ESI Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd0325901/pd0325901/pmc09106331-7-0-4
Average 90 stars, based on 1 article reviews
pd-0325901 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


TGF-β and Hippo signaling coordinately regulate CYR61 gene transcription. A and B , HCCLM3 or HLE cells were treated with 2.5 ng/ml of TGF-β1 in the presence or absence of small chemical inhibitors of different signaling pathways for 24 h, followed by gene expression analyses by quantitative PCR ( A ) or Western blotting ( B ). TGF-β type I receptor inhibitor, SB431542 (5 μM); YAP inhibitor, verteporfin (5 μM); MEK inhibitor, PD0325901 (5 μM); JNK inhibitor, SP600125 (5 μM); GSK-3 inhibitor, SB216763 (5 μM); NF-κB inhibitor, JSH-23 (5 μM); PI3K inhibitor, LY294002 (5 μM); ERK1/2 inhibitor, LY3214996 (5 μM). C , HLE or HCCLM3 cells treated with 2.5 ng/ml of TGF-β1 and/or 3 μM of XMU-MP-1 for 24 h were harvested for protein expression detection by Western blotting. D and E , HLE or HCCLM3 cells were treated with 2.5 ng/ml of TGF-β1 ( D ) or 3 μM of XMU-MP-1 ( E ) for 24 h, in the presence or absence of 5 μM of SB431542 and/or 5 μM of verteporfin. Then cells were analyzed by Western blotting. F and G , liver cancer cells transfected with siRNAs were treated with or without 2.5 ng/ml of TGF-β1 ( F ) or 3 μM of XMU-MP-1 ( G ) for 24 h before being harvested for Western blotting analyses. TGF-β, transforming growth factor-β.

Journal: The Journal of Biological Chemistry

Article Title: Upregulation of CYR61 by TGF-β and YAP signaling exerts a counter-suppression of hepatocellular carcinoma

doi: 10.1016/j.jbc.2024.107208

Figure Lengend Snippet: TGF-β and Hippo signaling coordinately regulate CYR61 gene transcription. A and B , HCCLM3 or HLE cells were treated with 2.5 ng/ml of TGF-β1 in the presence or absence of small chemical inhibitors of different signaling pathways for 24 h, followed by gene expression analyses by quantitative PCR ( A ) or Western blotting ( B ). TGF-β type I receptor inhibitor, SB431542 (5 μM); YAP inhibitor, verteporfin (5 μM); MEK inhibitor, PD0325901 (5 μM); JNK inhibitor, SP600125 (5 μM); GSK-3 inhibitor, SB216763 (5 μM); NF-κB inhibitor, JSH-23 (5 μM); PI3K inhibitor, LY294002 (5 μM); ERK1/2 inhibitor, LY3214996 (5 μM). C , HLE or HCCLM3 cells treated with 2.5 ng/ml of TGF-β1 and/or 3 μM of XMU-MP-1 for 24 h were harvested for protein expression detection by Western blotting. D and E , HLE or HCCLM3 cells were treated with 2.5 ng/ml of TGF-β1 ( D ) or 3 μM of XMU-MP-1 ( E ) for 24 h, in the presence or absence of 5 μM of SB431542 and/or 5 μM of verteporfin. Then cells were analyzed by Western blotting. F and G , liver cancer cells transfected with siRNAs were treated with or without 2.5 ng/ml of TGF-β1 ( F ) or 3 μM of XMU-MP-1 ( G ) for 24 h before being harvested for Western blotting analyses. TGF-β, transforming growth factor-β.

Article Snippet: Small chemical inhibitors, such as JSH-23 (HY-13982), SB216763 (HY-12012), verteporfin (HY-B0146), SB431542 (HY-10431), PD0325901 (HY-131295), SP600125 (HY-12041), LY3214996 (HY-101494), and LY294002 (HY-10108), were all purchased from MedChemExpress (MCE), while XMU-MP-1 was obtained from AbMole (M9057).

Techniques: Protein-Protein interactions, Gene Expression, Real-time Polymerase Chain Reaction, Western Blot, Expressing, Transfection

Journal: iScience

Article Title: Electrically synchronizing and modulating the dynamics of ERK activation to regulate cell fate

doi: 10.1016/j.isci.2021.103240

Figure Lengend Snippet:

Article Snippet: PD325901 MEK inhibitor , Cell signaling , Cat#79241S.

Techniques: Recombinant, Plasmid Preparation, Software

a Schematic overview of the loss-of-function screen experimental setup. Haploid parthenogenetic hESCs infected with a genome-wide CRISPR/Cas9 sgRNA library, were stained with an antibody against the paternally expressed gene PEG10 (normally silenced in these cells). This was followed by FACS sorting to isolate the PEG10-positive (PEG10 + ) cell population. Finally, targeted DNA sequencing of sgRNAs identifies enriched genes mutated in PEG10 + cells compared with unsorted control. b Histogram showing the flow cytometry analysis of PEG10 staining in androgenetic (blue) vs. parthenogenetic (red) cells. c Representative scatter plots of the flow cytometry analysis of PEG10 staining in secondary only control (left), haploid parthenogenetic CRISPR/Cas9 library cells (center) and bi-parental cells (right). y Axis represents the fluorescence intensity of PEG10 staining, while the x axis represents the autofluorescence signal. d Volcano plot showing the median log 2 fold change (FC) of normalized sgRNA read counts (calculated by edgeR) per gene, between PEG10 + and unsorted control ( x axis, values are normalized to zero. n = 4 replicate screens). y Axis represents −log 10 of the P value (two-sample, two-sided Kolmogorov-Smirnov test). Marked in blue are enriched genes having log FC > 0.5 (equivalent to normalized value >1.4) and P value < 0.05. Representative genes included in the “EpiFactors” database (orange), zinc finger proteins (purple) and tumor suppressors (blue) are indicated. e Pie chart subgrouping the 115 candidate genes by function (after removing genes enriched in the PEG10-negative control). Chromatin-related genes are further divided to subcategories: Genes included in the EpiFactors database, genes encoding zinc finger proteins (ZNFP) and those encoding transcription factors (TF). f Mean expression FC of PEGs between hpESCs treated with the MEK/ERK inhibitor PD0325901 and DMSO. n = 4 replicates from each treatment in two different cell lines. Data are presented as mean ± SEM. Shown are PEGs with FC > 1. P values are listed in gray (one-tailed, paired t -test).

Journal: Nature Communications

Article Title: Identifying regulators of parental imprinting by CRISPR/Cas9 screening in haploid human embryonic stem cells

doi: 10.1038/s41467-021-26949-7

Figure Lengend Snippet: a Schematic overview of the loss-of-function screen experimental setup. Haploid parthenogenetic hESCs infected with a genome-wide CRISPR/Cas9 sgRNA library, were stained with an antibody against the paternally expressed gene PEG10 (normally silenced in these cells). This was followed by FACS sorting to isolate the PEG10-positive (PEG10 + ) cell population. Finally, targeted DNA sequencing of sgRNAs identifies enriched genes mutated in PEG10 + cells compared with unsorted control. b Histogram showing the flow cytometry analysis of PEG10 staining in androgenetic (blue) vs. parthenogenetic (red) cells. c Representative scatter plots of the flow cytometry analysis of PEG10 staining in secondary only control (left), haploid parthenogenetic CRISPR/Cas9 library cells (center) and bi-parental cells (right). y Axis represents the fluorescence intensity of PEG10 staining, while the x axis represents the autofluorescence signal. d Volcano plot showing the median log 2 fold change (FC) of normalized sgRNA read counts (calculated by edgeR) per gene, between PEG10 + and unsorted control ( x axis, values are normalized to zero. n = 4 replicate screens). y Axis represents −log 10 of the P value (two-sample, two-sided Kolmogorov-Smirnov test). Marked in blue are enriched genes having log FC > 0.5 (equivalent to normalized value >1.4) and P value < 0.05. Representative genes included in the “EpiFactors” database (orange), zinc finger proteins (purple) and tumor suppressors (blue) are indicated. e Pie chart subgrouping the 115 candidate genes by function (after removing genes enriched in the PEG10-negative control). Chromatin-related genes are further divided to subcategories: Genes included in the EpiFactors database, genes encoding zinc finger proteins (ZNFP) and those encoding transcription factors (TF). f Mean expression FC of PEGs between hpESCs treated with the MEK/ERK inhibitor PD0325901 and DMSO. n = 4 replicates from each treatment in two different cell lines. Data are presented as mean ± SEM. Shown are PEGs with FC > 1. P values are listed in gray (one-tailed, paired t -test).

Article Snippet: Then bFGF (FGF2) was removed from the medium with addition of 25 μM PD0325901 (Biogems #3911091) or 0.1% DMSO as control for 5 days.

Techniques: Infection, Genome Wide, CRISPR, Staining, DNA Sequencing, Control, Flow Cytometry, Fluorescence, Negative Control, Expressing, One-tailed Test

Key Resources Table

Journal: Molecular cell

Article Title: Members of an array of zinc finger proteins specify distinct Hox chromatin boundaries

doi: 10.1016/j.molcel.2024.08.007

Figure Lengend Snippet: Key Resources Table

Article Snippet: MEK1/2 inhibitor (PD0325901) , Stemgent , #04-0006-base.

Techniques: Virus, Recombinant, Magnetic Beads, SYBR Green Assay, Western Blot, Clone Assay, Plasmid Preparation, Software, Injection